GLP-1 receptor agonists affect sexual function differently across individuals and influencing libido and hormone levels in ...

This multi-ancestry genomic study identifies key genetic loci underlying erectile dysfunction and shows that ED risk is shaped by both cardiometabolic and substance use–related genetic pathways. Using ...

The U.S. Food and Drug Administration has approved Otsuka's injectable drug to treat patients with a potentially ...

Summary • Can-Fite BioPharma Ltd. (CANF) stock surged 20.3% to $0.3514 after a patent allowance announcement for CF602 in ...

Genetic hearing loss may be reversible, early research suggests. Scientists test arginine and sildenafil treatments for ...

A healthy mouth is also key to a healthy body, as gum disease has been linked to non-communicable diseases such as diabetes, ...

An update from Can-Fite BioPharma ( ($CANF) ) is now available. On November 20, 2025, Can-Fite BioPharma Ltd. announced that its erectile ...

CF602 is a novel A3AR allosteric modulator that enhances the receptor activity in the presence of the native ligand. The ...

Study found drugs used to prevent shingles and treat erectile dysfunction could be promising for Alzheimer’s patients ...

Considering that about 5% of Generation Z take antidepressants, could this explain why so many report a disinterest in dating and settling down?

The infamous little blue pill that keeps men up and at ’em may improve a different kind of hardness — hardness of hearing, ...

Another common side effect is feeling tired all the time. Beta-blockers, for example, slow down the heart, which can make a person feel sluggish or low on energy. This can be hard for men who are ...